Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Beta-Defensin 2 in Preventing Preterm Birth with Chorioamnionitis: Insights into Inflammatory Responses and Epithelial Barrier Protection. | Int J Mol Sci | 2025 | 40076749 | PubTator, text mining | PubMed |
| Antimicrobial Peptides (AMPs) Are Not Increased in Asymptomatic Bacteriuria in Healthy Older Adult Patients. | J Am Geriatr Soc | 2025 | 40062707 | PubTator, text mining | PubMed |
| Do Melanocytes Have a Role in Controlling Epidermal Bacterial Colonisation and the Skin Microbiome? | Exp Dermatol | 2025 | 40051134 | PubTator, text mining | PubMed |
| Distinct anti-microbial peptides expression patterns and microbiome profiles in skin of Tunisian endemic Pemphigus foliaceus patients. | Arch Dermatol Res | 2025 | 40009223 | PubTator, text mining | PubMed |
| Associations between plasma proteins and psychological wellbeing: evidence from over 20 years of the English Longitudinal Study of Ageing. | medRxiv | 2025 | 39974132 | PubTator, text mining | PubMed |
| Exploring the Interaction of RBD with Human β Defensin Type 2 Point Mutants: Insights from Molecular Dynamics Simulations. | J Phys Chem B | 2025 | 39929747 | PubTator, text mining | PubMed |
| Computational Elucidation of Human β-Defensin-2 as a Dual Inhibitor of MMP-9 and PKC-βII for Diabetic Wound Management. | ACS Omega | 2025 | 39926537 | PubTator, text mining | PubMed |
| A patent review of BRD4 inhibitors (2020-present). | Expert Opin Ther Pat | 2025 | 39918129 | PubTator, text mining | PubMed |
| Design and Evaluation of Novel Selective BET BD2 Inhibitors by Combining QSAR, Molecular Docking and Molecular Dynamics Simulation Techniques. | Chem Biodivers | 2025 | 39835390 | PubTator, text mining | PubMed |
| Functional Annotation of Bipolar Disorder 2 Risk Location Implicates Novel Susceptibility Genes. | Neuropsychobiology | 2025 | 39809235 | PubTator, text mining | PubMed |
| EP-0108A is a moderation selectively BRD4 BD2 inhibitor with potential AML tumor suppression. | Anticancer Drugs | 2025 | 39259687 | PubTator, text mining | PubMed |
| Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1. | J Invest Dermatol | 2025 | 39004117 | PubTator, text mining | PubMed |
| Bacillus subtilis Induces Human Beta Defensin-2 Through its Lipoproteins in Human Intestinal Epithelial Cells. | Probiotics Antimicrob Proteins | 2025 | 38376819 | PubTator, text mining | PubMed |
| Effects of the Tobacco Defensin NaD1 Against Susceptible and Resistant Strains of Candida albicans. | Pathogens | 2024 | 39770352 | PubTator, text mining | PubMed |
| Assesment of Salivary and Serum Levels of HBD2 in Patients with Chronic Angioedema. | J Clin Med | 2024 | 39768474 | PubTator, text mining | PubMed |
| Role of Toll-like receptor 2 during infection of Leptospira spp: A systematic review. | PLoS One | 2024 | 39729468 | PubTator, text mining | PubMed |
| BODIPYS Based Fluorescent Markers To Monitor Autophagic Lysosomes and Lipid Droplets in TNBC. | ACS Med Chem Lett | 2024 | 39691523 | PubTator, text mining | PubMed |
| A multi-epitope self-amplifying mRNA SARS-CoV-2 vaccine design using a reverse vaccinology approach. | Res Pharm Sci | 2024 | 39691299 | PubTator, text mining | PubMed |
| Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors. | J Med Chem | 2024 | 39602227 | PubTator, text mining | PubMed |
| Possible immunomodulatory role of Filifactor alocis through beta-defensin 2 in gingival keratinocytes. | Clin Oral Investig | 2024 | 39592494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=7